Veopoz 61755-0014
Generic: Pozelimab
Product NDC
61755-0014- Manufacturer
- Regeneron Pharmaceuticals, Inc.
- Dosage Form
- Injection, Solution
- Route
- Intravenous And Subcutaneous
- Product Type
- Human Prescription Drug
- Marketing Start
- August 18, 2023
- Listing Expires
- December 31, 2026
- Application
- BLA761339
Need to source Veopoz? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.
Active Ingredients
| Ingredient | Strength |
|---|---|
| Pozelimab | 200 mg/mL |
Drug Class
Complement Inhibitor [EPC]Complement Inhibitor [EPC]Complement Inhibitors [MoA]
Packaging Options(1)
1 VIAL, SINGLE-DOSE in 1 CARTON (61755-014-01) / 2 mL in 1 VIAL, SINGLE-DOSE (61755-014-00)